Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050 NEC Corporation Mar 05, 2024 08:05 HKT/SGT Read More
エーザイ、第18回アルツハイマー・パーキンソン病学会（AD/PDTM2024）において、レカネマブをはじめとするアルツハイマー病に関する最新研究成果を発表 Eisai Feb 29, 2024 11:00 JST Read More
タイプライター・セラピューティクス、RAキャピタル・マネジメントとANベンチャーズをリードとする投資家から500万ドルを資金調達 Typewriter Therapeutics Feb 27, 2024 12:00 JST Read More
Eisai to Boost Initiatives on Greenhouse Gas Reduction, Aiming to Achieve Net Zero by 2050 Eisai Feb 21, 2024 14:26 HKT/SGT Read More
Eisai Selected for 'Human Capital Leaders 2023' and 'Human Capital Management Gold Quality', Recognized as Company Committed to Excellent Management and Disclosure of Human Capital Initiatives Eisai Feb 20, 2024 08:35 HKT/SGT Read More
Eisai: Metoject Subcutaneous Injection Pen (Methotrexate) Pen-Type Autoinjector Approved in Japan Eisai Feb 16, 2024 08:31 HKT/SGT Read More
Sysmex and Hitachi High-Tech Agree to Collaborate on Development of New Genetic Testing Systems Hitachi, Ltd. Feb 08, 2024 14:04 HKT/SGT Read More
China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro(R) China Medical System Holdings Ltd. Feb 04, 2024 10:00 JST Read More
Eisai Commences Fully-Fledged Business Activities at Pharma Sales Subsidiary in South Africa Eisai Feb 01, 2024 17:04 HKT/SGT Read More
BioAdaptives' Subsidiary, Livestock Impact, Inc. Celebrates Banner 2023 Equine Championship Titles Attributed to Its Advanced Proprietary Supplement Products BioAdaptives, Inc. Feb 01, 2024 04:00 HKT/SGT Read More
Eisai Submits New Drug Application for Mecobalamin Ultrahigh-Dose Formulation in Japan for the Indication of Amyotrophic Lateral Sclerosis Eisai Jan 26, 2024 15:26 HKT/SGT Read More
Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd Olympus Jan 24, 2024 14:00 HKT/SGT Read More
Eisai: Antiepileptic Drug Fycompa Injection Formulation Approved in Japan Eisai Jan 18, 2024 14:12 HKT/SGT Read More
JCB and Sunway Healthcare Group Signed Memorandum of Understanding for Medical Tourism to Malaysia JCB Jan 18, 2024 14:00 HKT/SGT Read More
Eisai Listed as a Global 100 Most Sustainable Corporation for the Eighth Time Eisai Jan 17, 2024 16:08 HKT/SGT Read More
Eisai Furthers Oncology Research Across Multiple Cancers at ASCO GI and ASCO GU 2024 Eisai Jan 16, 2024 09:25 HKT/SGT Read More
Eisai: The Scientific Advisory Group (SAG) to Convene to Discuss the Marketing Authorization Application for lecanemab in the EU Eisai Jan 11, 2024 15:33 HKT/SGT Read More
